Skyline Therapeutics
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.skytx.comRevenue
<$5 MillionIndustry
About Skyline Therapeutics
Skyline Therapeutics is a fully-integrated gene therapy company focused on addressing unmet medical needs for patients with rare or severe diseases through the development of novel therapies. The company has established an advanced adeno-associated virus (AAV) based platform that integrates capsid discovery, vector engineering, process development, and GMP manufacturing. Their innovative capDRIVE platform enables efficient identification of novel AAV capsids, leading to significant therapeutic advancements. Skyline Therapeutics aims to provide life-changing benefits to patients by transforming cutting-edge gene therapy technologies into effective treatments.Explore more
SIC Code 28,283NAICS Code 32,325Show moreSkyline Therapeutics Org Chart
Compare Similar Companies to Skyline Therapeutics
Compare insights from companies similar to Skyline Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Skyline Therapeutics Tech Stack
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Skyline Therapeutics
Sign Up For FreeTo access detailed company insights
Skyline Therapeutics is a fully-integrated gene therapy company focused on addressing unmet medical needs for patients with rare or severe diseases through the development of novel therapies. The company has established an advanced adeno-associated virus (AAV) based platform that integrates capsid discovery, vector engineering, process development,... Read More